Tokyo, April 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061377) titled 'Exploratory study on the effects of a foot bone-strengthening program on b... Read More
Tokyo, April 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061376) titled 'Effects and associations of exercise and health support programs including... Read More
Tokyo, April 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060705) titled 'A study to examine whether AI avatar-based pre-discharge explanations impr... Read More
Geneva, May 4 -- International Clinical Trials Registry received information related to the study (RBR-10tkjh3t) titled 'Effectiveness and durability of ready-to-use botulinum toxin A formulations (Re... Read More
Geneva, May 4 -- International Clinical Trials Registry received information related to the study (TCTR20260426001) titled 'Effectiveness of a Home-Based Exercise and Nutrition Program on Muscle Mass,... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550387) titled 'A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute Sc... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549282) titled 'Use Dexmedetomidine To Protect Myocardial Injury Evaluation' on April 09. Brief Summary: ... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550127) titled 'Peri-implantitis Management: Surgical and Maintenance Outcomes' on April 09. Brief Summar... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550270) titled 'Body Weight-Supported and Virtual Reality Gait Training in Stroke Patients' on March 25. ... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550452) titled 'Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atop... Read More